Sarah Shigdar
Sarah Shigdar
Verified email at
Cited by
Cited by
Cancer stem cells: a contentious hypothesis now moving forward
ML O’Connor, D Xiang, S Shigdar, J Macdonald, Y Li, T Wang, C Pu, ...
Cancer letters 344 (2), 180-187, 2014
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
S Shigdar, J Lin, Y Yu, M Pastuovic, M Wei, W Duan
Cancer science 102 (5), 991-998, 2011
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
WD Dongxi Xiang, Sarah Shigdar, Greg Qiao, Tao Wang, Abbas Z. Kouzani, Shu ...
Theranostics 5 (1), 23-42, 2015
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, ...
The international journal of biochemistry & cell biology 45 (12), 2736-2748, 2013
RNA aptamers targeting cancer stem cell marker CD133
S Shigdar, L Qiao, SF Zhou, D Xiang, T Wang, Y Li, LY Lim, L Kong, L Li, ...
Cancer letters 330 (1), 84-95, 2013
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells
L Li, D Xiang, S Shigdar, W Yang, Q Li, J Lin, K Liu, W Duan
International journal of nanomedicine 9, 1083, 2014
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo
D Xiang, Y Zheng, W Duan, X Li, J Yin, S Shigdar, ML O’Connor, ...
International journal of nanomedicine 8, 4103, 2013
Cancer stem cell targeted therapy: progress amid controversies
T Wang, S Shigdar, MP Gantier, Y Hou, L Wang, Y Li, H Al Shamaileh, ...
Oncotarget 6 (42), 44191, 2015
CD44 variant 6 is associated with prostate cancer metastasis and chemo‐/radioresistance
J Ni, PJ Cozzi, JL Hao, J Beretov, L Chang, W Duan, S Shigdar, ...
The Prostate 74 (6), 602-617, 2014
Aptamers as theranostic agents: modifications, serum stability and functionalisation
S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al. Shamaileh, ...
Sensors 13 (10), 13624-13637, 2013
Superior performance of aptamer in tumor penetration over antibody: implication of aptamer-based theranostics in solid tumors
D Xiang, C Zheng, SF Zhou, S Qiao, PHL Tran, C Pu, Y Li, L Kong, ...
Theranostics 5 (10), 1083, 2015
Inflammation and cancer stem cells
S Shigdar, Y Li, S Bhattacharya, M O’Connor, C Pu, J Lin, T Wang, ...
Cancer letters 345 (2), 271-278, 2014
EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model
T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ...
Theranostics 5 (12), 1456, 2015
Challenges and opportunities for siRNA-based cancer treatment
T Wang, S Shigdar, H Al Shamaileh, MP Gantier, W Yin, D Xiang, L Wang, ...
Cancer letters 387, 77-83, 2017
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
J Ni, PJ Cozzi, W Duan, S Shigdar, PH Graham, KH John, Y Li
Cancer and Metastasis Reviews 31 (3), 779-791, 2012
Development of a bifunctional aptamer targeting the transferrin receptor and epithelial cell adhesion molecule (EpCAM) for the treatment of brain cancer metastases
J Macdonald, J Henri, L Goodman, D Xiang, W Duan, S Shigdar
ACS chemical neuroscience 8 (4), 777-784, 2017
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles
L Chen, X She, T Wang, L He, S Shigdar, W Duan, L Kong
Nanoscale 7 (33), 14080-14092, 2015
Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery
X She, L Chen, L Velleman, C Li, H Zhu, C He, T Wang, S Shigdar, ...
Journal of Colloid and Interface Science 445, 151-160, 2015
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
D Xiang, S Shigdar, AG Bean, M Bruce, W Yang, M Mathesh, T Wang, ...
Theranostics 7 (17), 4071, 2017
The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion
PM Dodson, J Haynes, J Starczynski, J Farmer, S Shigdar, G Fegan, ...
Eye 17 (6), 772-777, 2003
The system can't perform the operation now. Try again later.
Articles 1–20